Brandt, SD; Baumann, MH; Partilla, JS; Kavanagh, PV; Power, JD; Talbot, B; Twamley, B; Mahony, O; O’Brien, J; Elliott, SP; Archer, RP; Patrick, J; Singh, K; Dempster, NM; Cosbey, SH. Characterization of a novel and potentially lethal designer drug (±)-cis-para-methyl-4-methylaminorex (4,4′-DMAR, or ‘Serotoni’) Drug Test. Anal., 1 Jul 2014, 6 (7-8), 684-695. 1.1 MB. https://doi.org/10.1002/dta.1668 #4,4′-DMAR MS,NMR,other
McLaughlin, G; Morris, N; Kavanagh, PV; Power, JD; Twamley, B; O’Brien, J; Talbot, B; Dowling, G; Mahony, O; Brandt, SD; Patrick, J; Archer, RP; Partilla, JS; Baumann, MH. Synthesis, characterization, and monoamine transporter activity of the new psychoactive substance 3′,4′-methylenedioxy-4-methylaminorex (MDMAR) Drug Test. Anal., 1 Jul 2015, 7 (7), 555-564. 517 kB. https://doi.org/10.1002/dta.1732
EMCDDA. New drugs in Europe, 2012, European Monitoring Centre for Drugs and Drug Addiction, Lisbon, 1 May 2013. 773 kB. #72
EMCDDA. New drugs in Europe, 2014, European Monitoring Centre for Drugs and Drug Addiction, Lisbon, 1 Jul 2015. 879 kB.
EMCDDA. New drugs in Europe, 2013, European Monitoring Centre for Drugs and Drug Addiction, Lisbon, 1 Jul 2014. 311 kB.
Zawilska, JB; Andrzejczak, D. Next generation of novel psychoactive substances on the horizon – A complex problem to face Drug Alcohol Depend., 1 Jan 2015, 157, 1-17. 3.0 MB. https://doi.org/10.1016/j.drugalcdep.2015.09.030
EMCDDA. Report on the risk assessment of 4,4′-DMAR, European Monitoring Centre for Drugs and Drug Addiction, Lisbon, 1 Oct 2015. 1.1 MB. #4,4′-DMAR MS,NMR
Chapman, SJ. Novel Psychoactive Spectra: NMR of (mostly) Novel Psychoactive Substances BLOTTER, 25 Jun 2018, 3 (2). https://doi.org/10.16889/isomerdesign-6 #4,4′-DMAR NMR
Maier, J; Mayer, FP; Luethi, D; Holy, M; Jäntsch, K; Reither, H; Hirtler, L; Hoener, MC; Liechti, ME; Pifl, C; Brandt, SD; Sitte, HH. The psychostimulant (±)-cis-4,4′-dimethylaminorex (4,4′-DMAR) interacts with human plasmalemmal and vesicular monoamine transporters Neuropharmacology, 1 Aug 2018, 138, 282–291. 877 kB. https://doi.org/10.1016/j.neuropharm.2018.06.018 #4,4’-DMAR
Maier, J; Mayer, FP; Brandt, SD; Sitte, HH. DARK classics in chemical neuroscience: Aminorex analogues ACS Chem. Neurosci., 17 Oct 2018, 9 (10), 2484–2502. 1.8 MB. https://doi.org/10.1021/acschemneuro.8b00415 #4-4′-Dimethylaminorex
Rickli, A; Kolaczynska, K; Hoener, MC; Liechti, ME. Pharmacological characterization of the aminorex analogs 4-MAR, 4,4′-DMAR, and 3,4-DMAR Neurotoxicology, 1 May 2019, 72, 95–100. 728 kB. https://doi.org/10.1016/j.neuro.2019.02.011 #4,4′-DMAR
Bork, W; Dahlenburg, R; Gimbel, M; Jacobsen-Bauer, A; Zörntlein, S. Herleitung Von Grenzwerten Der „nicht Geringen Menge“ Im Sinne Des Btmg Toxichem Krimtech, 1 Jan 2019, 86 (1), 5–91. 4.4 MB. #AP-003